Cargando…

Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome

BACKGROUND: Macrophage activation syndrome (MAS) is a potentially fatal complication of systemic inflammation. HMGB1 is a nuclear protein released extracellularly during proinflammatory lytic cell death or secreted by activated macrophages, NK cells, and additional cell types during infection or ste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palmblad, Karin, Schierbeck, Hanna, Sundberg, Erik, Horne, Anna-Carin, Erlandsson Harris, Helena, Henter, Jan-Inge, Andersson, Ulf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111379/ https://www.ncbi.nlm.nih.gov/pubmed/33975537 http://dx.doi.org/10.1186/s10020-021-00308-0

Ejemplares similares

Cytokine active disulfide-HMGB1 increased during severe macrophage activation syndrome
por: Schierbeck, Hanna, et al.
Publicado: (2014)

Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
por: Palmblad, Karin, et al.
Publicado: (2020)

Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
por: Palmblad, Karin, et al.
Publicado: (2020)

Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis
por: Palmblad, Karin, et al.
Publicado: (2007)

Etoposide in patients with rheuma-associated hemophagocytic lymphohistiocytosis / macrophage activation syndrome
por: Henter, Jan-Inge, et al.
Publicado: (2011)

High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts
por: Wähämaa, Heidi, et al.
Publicado: (2011)

HMGB1 is a potent proinflammatory mediator expressed abundantly in chronic synovitis
por: Andersson, UG, et al.
Publicado: (2002)

Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis
por: Östberg, Therese, et al.
Publicado: (2008)

Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study
por: Qu, Heshuang, et al.
Publicado: (2021)

Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients – a prospective clinical study
por: Sundberg, Erik, et al.
Publicado: (2008)

High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease
por: Pisetsky, David S, et al.
Publicado: (2008)

Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus
por: Wirestam, Lina, et al.
Publicado: (2015)

Systemic HMGB1 Neutralization Prevents Postoperative Neurocognitive Dysfunction in Aged Rats
por: Terrando, Niccolò, et al.
Publicado: (2016)

Redox modifications of cysteine residues regulate the cytokine activity of HMGB1
por: Yang, Huan, et al.
Publicado: (2021)

Disulfide and Fully Reduced HMGB1 Induce Different Macrophage Polarization and Migration Patterns
por: Salo, Henna, et al.
Publicado: (2021)

Transcriptomic Profiling Reveals That HMGB1 Induces Macrophage Polarization Different from Classical M1
por: Qu, Heshuang, et al.
Publicado: (2022)

Juvenile idiopathic arthritis and risk of cancer before and after the introduction of biological therapies
por: Horne, AnnaCarin, et al.
Publicado: (2019)

Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis: a therapeutic study
por: Palmblad, K, et al.
Publicado: (2001)

Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
por: Siderov, J, et al.
Publicado: (2002)

Cleavage of HMGB1 by Proteolytic Enzymes Associated with Inflammatory Conditions
por: Sowinska, Agnieszka, et al.
Publicado: (2020)

HMGB1, a new proinflammatory molecule of interest in polymyositis and dermatomyositis patients
por: Grundtman, C, et al.
Publicado: (2003)

Expression of Concern to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)
por: Yang, Huan, et al.
Publicado: (2020)

Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)
por: Yang, Huan, et al.
Publicado: (2020)

High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes
por: Andersson, Ulf, et al.
Publicado: (2000)

Ligation of free HMGB1 to TLR2 in the absence of ligand is negatively regulated by the C-terminal tail domain
por: Aucott, Hannah, et al.
Publicado: (2018)

Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity
por: Lundberg, Karin, et al.
Publicado: (2005)

Nonhistone Proteins HMGB1 and HMGB2 Differentially Modulate the Response of Human Embryonic Stem Cells and the Progenitor Cells to the Anticancer Drug Etoposide
por: Bagherpoor, Alireza Jian, et al.
Publicado: (2020)

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
por: Yang, Huan, et al.
Publicado: (2019)

Novel role of PKR in inflammasome activation and HMGB1 release
por: Lu, Ben, et al.
Publicado: (2012)

Targeting Inflammation Driven by HMGB1
por: Yang, Huan, et al.
Publicado: (2020)

How to Treat Involvement of the Central Nervous System in Hemophagocytic Lymphohistiocytosis?
por: Horne, AnnaCarin, et al.
Publicado: (2017)

HMGB1 is a critical molecule in the pathogenesis of Gram-negative sepsis()
por: Andersson, Ulf, et al.
Publicado: (2022)

Compton coincidence in silicon photon-counting CT detectors
por: Sundberg, Christel, et al.
Publicado: (2022)

Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours
por: Fleischhack, G, et al.
Publicado: (2001)

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.
por: de Jong, R. S., et al.
Publicado: (1997)

Neurons Are a Primary Driver of Inflammation via Release of HMGB1
por: Yang, Huan, et al.
Publicado: (2021)

TREM-1, HMGB1 and RAGE in the Shoulder Tendon: Dual Mechanisms for Inflammation Based on the Coincidence of Glenohumeral Arthritis
por: Thankam, Finosh G., et al.
Publicado: (2016)

Transcriptional Reactivation of Lignin Biosynthesis for the Heterologous Production of Etoposide Aglycone in Nicotiana benthamiana
por: Kim, Stacie S., et al.
Publicado: (2022)

Post-Translational Modification of HMGB1 Disulfide Bonds in Stimulating and Inhibiting Inflammation
por: Andersson, Ulf, et al.
Publicado: (2021)

Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile.
por: de Jong, R. S., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_db3vqjsbi4m7slm1iirt94jj0r